Revlimid

Which of These 5 Will Be the Best-Selling Drug Worldwide in 2020?
Motley Fool
Sat, 09/16/17 - 12:01 pm
AbbVie
Humira
Celgene
Revlimid
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
Biogen
aducanumab
Celgene to fork over $280M to wrap a whistleblower's Revlimid marketing claims
Fierce Pharma
Wed, 07/26/17 - 10:23 pm
Celgene
Revlimid
whistleblowers
off-label
False Claims Act
Amgen's battered Kyprolis nabs a survival win, slashing death risk in Revlimid-chemo combo
Fierce Pharma
Fri, 07/14/17 - 07:54 am
Amgen
Kyprolis
Revlimid
Celgene
Takeda
Velcade
Multiple Myeloma
These 5 Cancer Drugs Will Be the Biggest Winners 5 Years From Now
Motley Fool
Mon, 07/10/17 - 11:34 pm
Celgene
Revlimid
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
AbbVie
JNJ
Imbruvica
Pfizer
Ibrance
cancer
The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion)
Motley Fool
Fri, 06/30/17 - 11:06 am
prescription data
Sanofi
Lantus
Roche
Herceptin
Avastin
Celgene
Revlimid
JNJ
Merck
Remicade
Biogen
Rituxan
Amgen
Enbrel
Gilead Sciences
Harvoni
AbbVie
Humira
Angry cancer patient sues Celgene over 500% jump in Revlimid cost
Fierce Pharma
Fri, 06/16/17 - 09:42 pm
patients
drug pricing
Celgene
Revlimid
5 Reasons Celgene Will Be a Top Biotech Stock for the Next Decade
Motley Fool
Thu, 03/9/17 - 09:54 am
Celgene
Revlimid
Pomalyst
Abraxane
Otezla
Celgene, BMS, Novartis expected to top 2022 orphan drug market worth $209B: report
Fierce Pharma
Sat, 03/4/17 - 01:59 pm
Celgene
Novartis
Bristol-Myers Squibb
orphan drugs
Revlimid
Celgene’s Revlimid Secures Label Expansion
Investopedia
Thu, 02/23/17 - 09:44 pm
Celgene
Revlimid
Inside Celgene’s Revlimid: Strong Patient Demand in 4Q16
Market Realist
Tue, 01/31/17 - 09:52 am
Celgene
Revlimid
Multiple Myeloma
Celgene’s Revlimid Expected to Post Strong Revenue in 2017
Market Realist
Tue, 01/24/17 - 09:58 am
Celgene
Revlimid
earnings
The Most Important Keys To Celgene's Pipeline
Seeking Alpha
Sat, 01/21/17 - 11:32 am
Celgene
Revlimid
Acceleron
Juno Therapeutics
Agios
Is Donald Trump Celgene's Biggest Risk in 2017?
Motley Fool
Tue, 01/17/17 - 10:23 pm
Celgene
Revlimid
drug pricing
Multiple Myeloma
Donald Trump
What's Next For Celgene
Motley Fool
Wed, 01/11/17 - 10:13 am
Celgene
JPMHC 2017
Otezla
ozanimod
Revlimid
Pomalyst
3 Biggest Risks for Celgene Corporation
Motley Fool
Thu, 12/15/16 - 06:44 pm
Celgene
Darzalex
Multiple Myeloma
Allergan
generics
Abraxane
Revlimid
3 Things to Watch as Celgene Corporation Reports Earnings
Motley Fool
Wed, 07/27/16 - 09:51 am
Celgene
earnings
Revlimid
Otezla
Celgene gives up on lucrative new use for linchpin drug Revlimid, clouding hopes for $1B-plus revenue boost
Fierce Pharma
Tue, 07/26/16 - 09:46 pm
Celgene
Revlimid
diffuse large B-cell lymphoma
Celgene drug fails to extend survival in lymphoma study
Yahoo/Reuters
Mon, 07/25/16 - 06:26 pm
Celgene
clinical trials
Revlimid
diffuse large B-cell lymphoma
This $6.7 Billion Drug Just Keeps Growing
Motley Fool
Sat, 07/2/16 - 12:32 pm
JNJ
Darzalex
Celgene
Revlimid
Celgene Can Count on Revlimid for Strong Revenue Growth
Bidness, ETC
Sun, 05/22/16 - 11:42 am
Celgene
Revlimid

Pages